Literature DB >> 6944140

Analysis of the presenting features of adult acute leukemia: the French-American-British classification.

C P Burns, J O Armitage, A L Frey, F R Dick, J E Jordan, R F Woolson.   

Abstract

The authors have performed a clinical and statistical analysis of the presenting features of adult acute leukemia classified according to the French-American-British (FAB) hematopathologic criteria. Observations were made on 70 variables of history, physical examination, and laboratory examination recorded for 195 patients seen during a recent six year interval. The incidence of each category as determined by consensus of three observers was L1, 9%; L2, 17%; L3, 3%; M1, 21%; M2, 22%; M3, 5%; M4, 21%; M5, 4%; and M6 1%. there were recurring features of each FAB category and for aggregated categories (myeloid, lymphoid). Some groups such as L1, M3, M4, and M5 were characterized by many distinctive characteristics. In contrast, the L2, M1, and M2 categories had few distinctive characteristics, although L3 shared many features with the other lymphoid groups. The distinctness of the categories was quantitated by stepwise discriminant analysis. Using only a few computer-selected clinical variables, the authors classified patients into the correct FAB category with an accuracy of over 65% for some groups. The accuracy in discriminating between lymphoid and myeloid groups, the important therapeutic distinction, was 82%. This study demonstrates that many of the categories defined by the FAB criteria have characteristic clinical features at presentation.

Entities:  

Mesh:

Year:  1981        PMID: 6944140     DOI: 10.1002/1097-0142(19810515)47:10<2460::aid-cncr2820471025>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia.

Authors:  Yun Chen; Yihang Pan; Yao Guo; Wanke Zhao; Wanting Tina Ho; Jianlong Wang; Mingjiang Xu; Feng-Chun Yang; Zhizhuang Joe Zhao
Journal:  Stem Cell Investig       Date:  2017-06-02

2.  Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients.

Authors:  Mikkael A Sekeres; Paul Elson; Matt E Kalaycio; Anjali S Advani; Edward A Copelan; Stefan Faderl; Hagop M Kantarjian; Elihu Estey
Journal:  Blood       Date:  2008-09-30       Impact factor: 22.113

3.  Relapsing acute non-lymphatic leukemia with changing phenotypes.

Authors:  M L Mlynek; H K Mahmoud; L D Leder
Journal:  Klin Wochenschr       Date:  1985-11-04

4.  Cytochemical determination of granulocyte elastase and chymotrypsin in human myeloid cells and its application in acquired deficiency states and diagnosis of myeloid leukemia.

Authors:  K Havemann; M Gramse; W D Gassel
Journal:  Klin Wochenschr       Date:  1983-01-03

5.  Long non-coding RNA LINC01268 promotes cell growth and inhibits cell apoptosis by modulating miR-217/SOS1 axis in acute myeloid leukemia.

Authors:  Beili Chen; Yuchuan Li; Yuwei Nie; Ailin Tang; Qin Zhou
Journal:  Braz J Med Biol Res       Date:  2020-06-26       Impact factor: 2.590

6.  A rare combination of acute myeloid leukemia with Vit B12 deficiency: Case report.

Authors:  Mohammad Nour Kitaz; Rama Zazo; Muhammad Alsabbagh; Muhammad Diabi; Salam Alnahar; Anwar Chammout
Journal:  Ann Med Surg (Lond)       Date:  2022-08-25

7.  Overexpression of MYCT1 Inhibits Proliferation and Induces Apoptosis in Human Acute Myeloid Leukemia HL-60 and KG-1a Cells in vitro and in vivo.

Authors:  Shuang Fu; Yu Fu; Fang Chen; Yanping Hu; Bi Quan; Jihong Zhang
Journal:  Front Pharmacol       Date:  2018-09-18       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.